COH:ASX
Cochlear Ltd
A$137.58
arrow_upward
+1.68%(+2.27) 1D
Sep 10, 4:10:07 PM GMT+10 · AUD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for COH...
Open
A$134.43
High
A$137.94
Low
A$133.95
Mkt. cap
9.00B
Avg. vol.
742.98K
Volume
318.72K
Dividend
2.51%
Quarterly dividend
A$0.86
Ex-dividend date
Sep 21, 2026
P/E ratio
61.21
52-wk high
A$303.74
52-wk low
A$88.74
EPS
A$2.25
Shares outstanding
65.40M
No. of employees
5K
Open
A$134.43
High
A$137.94
Low
A$133.95
Mkt. cap
9.00B
Avg. vol.
742.98K
Volume
318.72K
Dividend
2.51%
Quarterly dividend
A$0.86
Ex-dividend date
Sep 21, 2026
P/E ratio
61.21
52-wk high
A$303.74
52-wk low
A$88.74
EPS
A$2.25
Shares outstanding
65.40M
No. of employees
5K
News stories
From web sources and news partners
Rask Media
·
22 hours ago
A deep dive into COH shares
Rask Media
·
2 days ago
Are COH shares or WOW shares better value in 2026?
Kalkine Media
·
3 days ago
What’s Behind Cochlear (ASX:COH) and Its Medical Device Business?
Profile
Cochlear is a medical device company that designs, manufactures, and supplies the Nucleus cochlear implant, the Hybrid electro-acoustic implant and the Baha bone conduction implant.
Based in Sydney, Cochlear was formed in 1981 as a subsidiary of Nucleus with finance from the Australian government to commercialise the implants pioneered by Dr. Graeme Clark, although the company later became separate. As of 2022, the company holds 50% of the cochlear implant market, with more than 250,000 people receiving one of Cochlear's implants as of 2015.
Cochlear was named Australia's most innovative company by the Intellectual Property Research Institute of Australia in 2002 and 2003, and one of the world's most innovative companies by Forbes in 2011. Wikipedia
About Cochlear Ltd
CEODig Howitt
Employees5.4K
Founded1981
HeadquartersSydney, New South Wales, Australia
SectorMedical device
Websitecochlear.com